KAM

Krensavage Asset Management Portfolio holdings

AUM $283M
1-Year Est. Return 69.04%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+69.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$283M
AUM Growth
+$48.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
18
New
Increased
Reduced
Closed

Top Buys

1
+$8.28M
2
+$6.5M
3
+$4.92M
4
BNTX icon
BioNTech
BNTX
+$2.03M

Top Sells

1
+$8.16M
2
+$3M
3
+$2.96M
4
SUPN icon
Supernus Pharmaceuticals
SUPN
+$2.43M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$1.94M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$25B
$44.5M 15.71%
91,282
-6,364
ENTA icon
2
Enanta Pharmaceuticals
ENTA
$416M
$43.6M 15.41%
2,766,390
+651,946
BMRN icon
3
BioMarin Pharmaceuticals
BMRN
$10.4B
$31.2M 11.02%
524,786
+119,336
JAZZ icon
4
Jazz Pharmaceuticals
JAZZ
$12.7B
$28.5M 10.08%
167,816
EXEL icon
5
Exelixis
EXEL
$11.1B
$21.6M 7.64%
493,526
-25,000
AVDL
6
DELISTED
Avadel Pharmaceuticals
AVDL
$18.4M 6.51%
855,860
-100,000
SNY icon
7
Sanofi
SNY
$110B
$15.7M 5.54%
323,946
SUPN icon
8
Supernus Pharmaceuticals
SUPN
$2.76B
$15.6M 5.5%
313,499
-49,980
CAH icon
9
Cardinal Health
CAH
$45.9B
$15.2M 5.35%
73,745
INDV icon
10
Indivior Pharmaceuticals
INDV
$4.59B
$12.2M 4.3%
339,532
VNDA icon
11
Vanda Pharmaceuticals
VNDA
$421M
$10.4M 3.68%
1,180,388
BNTX icon
12
BioNTech
BNTX
$24.7B
$9.47M 3.35%
99,523
+20,157
GSK icon
13
GSK
GSK
$103B
$4.74M 1.68%
96,729
-175,000
RARE icon
14
Ultragenyx Pharmaceutical
RARE
$2.44B
$3.44M 1.22%
+149,634
REGN icon
15
Regeneron Pharmaceuticals
REGN
$73.5B
$3.09M 1.09%
4,000
ALKS icon
16
Alkermes
ALKS
$5.55B
$3.02M 1.07%
107,822
-100,000
BIIB icon
17
Biogen
BIIB
$27.5B
$1.76M 0.62%
10,000
EOLS icon
18
Evolus
EOLS
$347M
$665K 0.23%
100,000